Hematology NewsRepurposed drug could revolutionize stem cell transplantationMarch 18, 2022TransplantB Cell LymphomaHodgkin LymphomaMultiple MyelomaPediatricsDLBCLCLL
Hematology NewsHodgkin-directed therapy may benefit patients with rare CLL subtypeMarch 10, 2022CLLHodgkin Lymphoma
Hematology NewsDKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
Hematology NewsFrontline brentuximab vedotin shows promise in high-risk pediatric Hodgkin lymphomaApril 21, 2021Hodgkin LymphomaLymphoma & Plasma Cell DisordersPediatrics
Oncology PracticeDon’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
Hematology NewsChildhood Hodgkin survivors have neurocognitive impairmentDecember 7, 2020Hodgkin LymphomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsEfforts to close the ‘AYA gap’ in lymphomaOctober 20, 2020Lymphoma & Plasma Cell DisordersB Cell LymphomaHodgkin LymphomaPatient & Survivor Care
Oncology PracticeSurvey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaLung CancerLeukemia, Myelodysplasia, Transplantation
Oncology PracticeHepatitis screening now for all patients with cancer on therapyAugust 6, 2020Patient & Survivor CareHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaB Cell LymphomaAggressive LymphomasCNS/Brain Cancer
Oncology PracticeEarly screening may halve breast cancer mortality in childhood cancer survivorsJuly 21, 2020Breast CancerPediatricsPreventive CarePatient & Survivor CareLymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsEczema may increase lymphoma risk, cohort studies suggestJune 24, 2020Hodgkin Lymphoma
Hematology NewsSafe to skip radiotherapy with negative PET in Hodgkin lymphomaJune 17, 2020Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeCancer risk elevated in hidradenitis suppurativa patientsJune 2, 2020Mixed TopicsHodgkin Lymphoma
Hematology NewsPembrolizumab prolonged PFS vs. brentuximab vedotin in r/r Hodgkin lymphomaJune 1, 2020Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Oncology Practice20% with cancer on checkpoint inhibitors get thyroid dysfunctionApril 2, 2020Hodgkin LymphomaBreast CancerLung CancerLymphoma & Plasma Cell DisordersGynecologic Cancer
